Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Benedetti

Showing results (261-270 of 265) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 265 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology GroupM J Piccart, J A Green, A J Lacave, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)I Ruscito, D Dimitrova, I Vasconcelos, et al.
British Journal of Cancer|August 31, 2006
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvisA Maggioni, P Benedetti Panici, T Dell'Anna, et al.
British Journal of Cancer|February 9, 2023
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum lineN Colombo, A Gadducci, J Sehouli, et al.
Pageof 27

Showing results (261-270 of 265) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 265 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology GroupM J Piccart, J A Green, A J Lacave, et al.
International Journal of Cancer|August 22, 1995
Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomasA Bellacosa, D de Feo, A K Godwin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD)I Ruscito, D Dimitrova, I Vasconcelos, et al.
British Journal of Cancer|August 31, 2006
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvisA Maggioni, P Benedetti Panici, T Dell'Anna, et al.
British Journal of Cancer|February 9, 2023
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum lineN Colombo, A Gadducci, J Sehouli, et al.
Pageof 27